FULC Fulcrum Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Jul 30, 2026
$3,69
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,83mínimo 52 semanas
$15,74máximo 52 semanas
Capitalización Bursátil (MRQ)
$281M
P/E
-3.1
BPA
$-1.18
Ingresos
$0
tus insignias
Rango 52S
$3–$16
Calificación del Analista
HOLD
Precio Objetivo
$4
P/E
-3.1
ROE
-26.6%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
FULC Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.69
Capitalización Bursátil (MRQ)
$281M
P/E
-3.1
BPA
$-1.18
Ingresos
$0
ROE
-26.6%
Rango 52S
$3–$16
FULC Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Acerca de Fulcrum Therapeutics, Inc. - Common Stock Descripción general de la empresa de Wikipedia
sectorHealthcare
industriaPharmaceuticals
empleados9
paísUS
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02020-12-31 → 2025-12-31
BPA$-1.182020-12-31 → 2025-12-31
Flujo de caja libre$-60M2019-12-31 → 2025-12-31
Margen neto·2020-12-31 → 2024-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | FULC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -3.1promedio 5A ≈-10.8 | ≈-10.8 | · | · | |
| P/C (MRQ) | 0.9promedio 5A ≈1.7 | ≈1.7 | 2.3 | Infravalorado | |
| Precio / FCF (TTM) | -4.3promedio 5A ≈-30.6 | ≈-30.6 | · | · | |
| Precio / Flujo de Caja (TTM) | -4.3promedio 5A ≈-33.8 | ≈-33.8 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.7promedio 5A ≈2.1 | ≈2.1 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | FULC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -23.9%promedio 5A ≈-28.9% | ≈-28.9% | -34.8% | De primer nivel | |
| ROE | -26.6%promedio 5A ≈-30.6% | ≈-30.6% | -42.1% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | FULC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 31.4promedio 5A ≈20.0 | ≈20.0 | 9.4 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 15.1promedio 5A ≈6.1 | ≈6.1 | 4.5 | En línea |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | FULC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 2752.0%promedio 5A ≈686.6% | ≈686.6% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 61.0% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | FULC | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.1 | ≈0.1 | 0.2 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
5.0%
Próximo informe
Oct 27, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Jul 27, 2026 | $-0.22 | $-0.22 | 2.0% |
| 31 de marzo de 2026 | $-0.25 | $-0.30 | 17.8% | |
| 31 de diciembre de 2025 | $-0.31 | $-0.32 | 1.7% | |
| 30 de septiembre de 2025 | $-0.31 | $-0.30 | -3.5% | |
| 30 de junio de 2025 | $-0.28 | $-0.30 | 5.3% | |
| 31 de marzo de 2025 | $-0.28 | $-0.30 | 6.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $80M | $3M | $6M | $19M | $9M | |
| R&D Expense | $56M | $63M | $72M | $77M | $70M | $59M | |
| SG&A Expense | $29M | $36M | $42M | $42M | $31M | $21M | |
| Operating Expenses | $85M | $102M | $113M | $119M | $100M | $80M | |
| Operating Income | $-85M | $-22M | $-111M | $-113M | $-81M | $-72M | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-75M | $-10M | $-97M | $-110M | $-81M | $-71M | |
| EPS (Basic) | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 | $-2.79 | |
| EPS (Diluted) | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 | $-2.79 | |
| Shares (Basic) | 63,355 | 61,984 | 61,310 | 44,991 | 35,361 | 25,354 | |
| Shares (Diluted) | 63,355 | 61,984 | 61,310 | 44,991 | 35,361 | 25,354 | |
| EBITDA | $-85M | $-22M | $-111M | $-113M | · | $-72M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $198M | $58M | $26M | $35M | $35M | $57M | |
| Prepaid Expense | $5M | $7M | $5M | $4M | $4M | $4M | |
| Other Current Assets | · | · | · | · | $0 | $74.0K | |
| Current Assets | $357M | $250M | $242M | $208M | $226M | $120M | |
| PP&E (Net) | $3M | $4M | $5M | $7M | $7M | $8M | |
| PP&E (Gross) | $18M | $18M | $18M | $18M | $16M | $15M | |
| Accum. Depreciation | $16M | $14M | $13M | $11M | $8M | $6M | |
| Other Non-current Assets | $538.0K | $10.0K | $2M | $2M | $542.0K | $578.0K | |
| Total Assets | $366M | $261M | $258M | $227M | $235M | $130M | |
| Accounts Payable | $2M | $1M | $3M | $4M | $5M | $4M | |
| Current Liabilities | $13M | $11M | $14M | $17M | $19M | $27M | |
| Capital Leases | $4M | $6M | $9M | $11M | $0 | · | |
| Other Non-current Liabilities | $197.0K | $197.0K | $197.0K | $197.0K | $0 | · | |
| Total Liabilities | $17M | $18M | $23M | $28M | $23M | $34M | |
| Common Stock | $67.0K | $54.0K | $62.0K | $52.0K | $41.0K | $28.0K | |
| Retained Earnings | $-594M | $-519M | $-510M | $-412M | $-302M | $-222M | |
| Treasury Stock | · | · | · | $0 | $0 | · | |
| AOCI | $174.0K | $130.0K | $-136.0K | $-797.0K | $-397.0K | $-2.0K | |
| Stockholders' Equity | $349M | $243M | $235M | $199M | $212M | $95M | |
| Liabilities + Equity | $366M | $261M | $258M | $227M | $235M | $130M | |
| Shares Outstanding | 66,578,891 | 53,968,303 | 61,915,367 | 52,099,211 | 40,626,224 | 27,941,566 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $12M | $15M | $15M | $13M | $11M | $7M | |
| Restructuring | $400.0K | $2M | · | $400.0K | · | · | |
| Operating Cash Flow | $-60M | $-2M | $-91M | $-97M | $-78M | $-54M | |
| CapEx | $314.0K | $278.0K | $508.0K | $2M | $2M | $1M | |
| Investing Cash Flow | $31M | $32M | $-37M | $12M | $-130M | $-57M | |
| Stock Issued | $4M | $3M | $777.0K | $4M | $4M | $1M | |
| Net Stock Activity | $4M | $3M | $777.0K | $4M | · | $1M | |
| Financing Cash Flow | $169M | $3M | $118M | $84M | $187M | $71M | |
| Net Change in Cash | $139M | $33M | $-10M | $-314.0K | $-22M | $-40M | |
| Free Cash Flow | $-60M | $-2M | $-91M | $-99M | · | $-55M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | -27.4% | -3945.2% | -1774.8% | · | -811.6% | |
| Net Margin | · | -12.2% | -3470.0% | -1732.4% | · | -802.7% | |
| EBITDA Margin | · | -27.4% | -3945.2% | -1774.8% | · | -811.6% | |
| ROA | -23.9% | -3.8% | -40.2% | -47.6% | · | -59.0% | |
| ROE | -26.6% | -3.9% | -39.7% | -52.3% | · | -70.8% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 27.4 | 22.6 | 17.7 | 12.4 | · | 4.5 | |
| Quick Ratio | 15.1 | 5.3 | 1.9 | 2.1 | · | 2.1 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.3 | 0.0 | 0.0 | · | 0.1 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.24 | $4.50 | $3.80 | $3.82 | · | $3.41 | |
| Revenue / Share | $0.00 | $1290.66 | $45.75 | $140.96 | · | · | |
| Cash Flow / Share | $-948.07 | $-35.78 | $-1483.69 | $-2157.10 | · | · | |
| Cash / Share | $2.97 | $1.08 | $0.41 | $0.67 | · | $2.04 | |
| EPS (TTM) | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 | $-2.79 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | 2752.0% | -55.8% | -66.9% | 117.2% | · | |
| Revenue CAGR 3Y | · | 61.0% | -31.8% | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $80M | $3M | $6M | $19M | $9M | |
| Net Income TTM | $-75M | $-10M | $-97M | $-110M | $-81M | $-71M | |
| Market Cap | $753M | $254M | $418M | $379M | · | $327M | |
| P/E | -9.6 | -29.4 | -4.2 | -3.0 | -7.7 | -4.2 | |
| P/S | · | 3.2 | 149.0 | 59.8 | · | 37.1 | |
| P/B | 2.2 | 1.0 | 1.8 | 1.9 | · | 3.4 | |
| P / Tangible Book | 2.2 | 1.0 | 1.8 | 1.9 | 3.4 | 3.4 | |
| P / Cash Flow | -12.5 | -114.4 | -4.6 | -3.9 | · | -6.1 | |
| P / FCF | -12.5 | -101.6 | -4.6 | -3.8 | · | -5.9 | |
| Earnings Yield | -10.4% | -3.4% | -23.6% | -33.5% | -13.0% | -23.8% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $80M | $0 | $871.0K | $759.0K | $880.0K | $295.0K | $685.0K | $1M | |
| R&D Expense | $12M | $14M | $15M | $14M | $13M | $13M | $12M | $15M | $17M | $20M | $19M | $18M | $18M | $17M | $19M | $15M | |
| SG&A Expense | $7M | $8M | $7M | $8M | $7M | $7M | $8M | $8M | $10M | $10M | $10M | $10M | $10M | $12M | $10M | $10M | |
| Operating Expenses | $29M | $22M | $23M | $22M | $20M | $20M | $19M | $25M | $28M | $30M | $29M | $28M | $28M | $28M | $29M | $26M | |
| Operating Income | $-29M | $-22M | $-23M | $-22M | $-20M | $-20M | $-19M | $-25M | $52M | $-30M | $-28M | $-27M | $-27M | $-28M | $-28M | $-24M | |
| Net Income | $-26M | $-19M | $-20M | $-20M | $-17M | $-18M | $-17M | $-22M | $55M | $-27M | $-25M | $-24M | $-24M | $-25M | $-26M | $-24M | |
| EPS (Basic) | $-0.34 | $-0.25 | $-0.31 | $-0.31 | $-0.28 | $-0.28 | $-0.27 | $-0.35 | $0.89 | $-0.43 | $-0.41 | $-0.39 | $-0.38 | $-0.41 | $-0.46 | $-0.51 | |
| EPS (Diluted) | $-0.34 | $-0.25 | $-0.31 | $-0.31 | $-0.28 | $-0.28 | $-0.25 | $-0.35 | $0.87 | $-0.43 | $-0.41 | $-0.39 | $-0.38 | $-0.41 | $-0.46 | $-0.51 | |
| Shares (Basic) | 76,264,000 | 76,215,000 | · | 62,597,000 | 62,544,000 | 62,479,000 | · | 62,409,000 | 62,205,000 | 61,984,000 | · | 61,823,000 | 61,794,000 | 59,722 | · | 46,213 | |
| Shares (Diluted) | 76,264,000 | 76,215,000 | · | 62,597,000 | 62,544,000 | 62,479,000 | · | 62,409,000 | 63,587,000 | 61,984,000 | · | 61,823,000 | 61,794,000 | 59,722 | · | 46,213 | |
| EBITDA | $-29M | $-22M | · | $-22M | $-20M | $-20M | · | $-25M | $52M | $-30M | · | $-27M | $-27M | $-28M | · | $-24M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $50M | $198M | $47M | $43M | $42M | $58M | $73M | $87M | $40M | $26M | $30M | $34M | $35M | $35M | $91M | |
| Prepaid Expense | $4M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | $4M | $5M | $5M | $5M | $4M | $5M | $4M | $5M | |
| Other Current Assets | · | · | · | · | $69.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $323M | $339M | $357M | $206M | $219M | $233M | $250M | $267M | $280M | $218M | $242M | $262M | $283M | $303M | $208M | $228M | |
| PP&E (Net) | $0 | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $6M | $6M | $7M | $7M | $7M | |
| PP&E (Gross) | $1M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M | |
| Accum. Depreciation | $1M | $15M | $16M | $15M | $15M | $15M | $14M | $14M | $14M | $13M | $13M | $12M | $12M | $11M | $11M | $10M | |
| Other Non-current Assets | $9.0K | $546.0K | $538.0K | $9.0K | $12.0K | $10.0K | $10.0K | $76.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $324M | $347M | $366M | $215M | $229M | $243M | $261M | $279M | $294M | $233M | $258M | $279M | $300M | $321M | $227M | $248M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $2M | $2M | $1M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $3M | |
| Current Liabilities | $10M | $10M | $13M | $12M | $9M | $8M | $11M | $15M | $13M | $11M | $14M | $14M | $15M | $14M | $17M | $15M | |
| Capital Leases | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | |
| Other Non-current Liabilities | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $447.0K | $320.0K | $197.0K | $197.0K | |
| Total Liabilities | $13M | $13M | $17M | $16M | $14M | $14M | $18M | $22M | $20M | $19M | $23M | $23M | $25M | $25M | $28M | $26M | |
| Common Stock | $76.0K | $67.0K | $67.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $62.0K | $62.0K | $62.0K | $62.0K | $62.0K | $62.0K | $52.0K | $52.0K | |
| Retained Earnings | $-639M | $-613M | $-594M | $-574M | $-554M | $-537M | $-519M | $-503M | $-481M | $-537M | $-510M | $-485M | $-461M | $-437M | $-412M | $-386M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | |
| AOCI | $-567.0K | $-513.0K | $174.0K | $241.0K | $82.0K | $70.0K | $130.0K | $379.0K | $-366.0K | $-434.0K | $-136.0K | $-886.0K | $-1M | $-651.0K | $-797.0K | $-921.0K | |
| Stockholders' Equity | $311M | $333M | $349M | $198M | $214M | $228M | $243M | $257M | $274M | $214M | $235M | $255M | $275M | $296M | $199M | $221M | |
| Liabilities + Equity | $324M | $347M | $366M | $215M | $229M | $243M | $261M | $279M | $294M | $233M | $258M | $279M | $300M | $321M | $227M | $248M | |
| Shares Outstanding | 76,285,157 | 66,608,096 | 66,578,891 | 54,108,438 | 54,091,588 | 53,979,306 | 53,968,303 | 53,938,661 | 62,250,631 | 62,141,011 | 61,915,367 | 52,099,211 | 52,099,211 | 61,758,994 | 52,099,211 | 52,049,913 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | |
| Restructuring | $4M | · | $400.0K | $0 | $0 | $0 | $2M | $0 | · | · | · | · | · | · | · | $400.0K | |
| Operating Cash Flow | $-16M | $-19M | $-17M | $-14M | $-14M | $-15M | $-17M | $-19M | $59M | $-25M | $-23M | $-23M | $-21M | $-24M | $-20M | $-28M | |
| CapEx | $108.0K | $8.0K | $159.0K | $90.0K | $65.0K | $0 | $231.0K | $19.0K | $0 | $28.0K | $77.0K | $65.0K | $195.0K | $171.0K | $116.0K | $283.0K | |
| Investing Cash Flow | $14M | $-128M | $-1M | $19M | $14M | $-777.0K | $2M | $4M | $-13M | $38M | $18M | $19M | $20M | $-94M | $-36M | $-2M | |
| Stock Issued | $356.0K | $21.0K | $4M | $64.0K | $301.0K | $0 | $83.0K | $635.0K | $377.0K | $2M | $287.0K | $0 | $142.0K | $348.0K | $267.0K | $93.0K | |
| Net Stock Activity | · | $21.0K | · | · | · | $0 | · | · | · | $2M | · | · | · | $348.0K | · | · | |
| Financing Cash Flow | $356.0K | $-312.0K | $168M | $64.0K | $301.0K | $0 | $83.0K | $635.0K | $377.0K | $2M | $287.0K | $0 | $142.0K | $118M | $218.0K | $81M | |
| Net Change in Cash | $-2M | $-147M | $150M | $4M | $414.0K | $-16M | $-14M | $-14M | $47M | $14M | $-5M | $-4M | $-768.0K | $-364.0K | $-56M | $51M | |
| Free Cash Flow | · | $-19M | · | · | · | $-15M | · | · | · | $-25M | · | · | · | $-24M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | 65.6% | · | · | -3615.3% | -3101.4% | -9471.2% | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | 69.3% | · | · | -3164.3% | -2702.6% | -8399.7% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | 65.6% | · | · | -3615.3% | -3101.4% | -9471.2% | · | · | |
| ROA | -9.5% | -6.4% | · | -7.9% | -6.6% | -7.4% | · | -7.8% | 22.6% | -10.1% | · | -9.1% | · | -9.2% | · | -9.4% | |
| ROE | -10.0% | -6.7% | · | -8.6% | -7.1% | -8.0% | · | -8.5% | 25.5% | -11.0% | · | -10.1% | · | -10.2% | · | -10.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.4 | 34.3 | · | 17.7 | 24.4 | 28.7 | · | 18.4 | 22.1 | 20.4 | · | 18.6 | · | 21.0 | · | 15.5 | |
| Quick Ratio | 4.7 | 5.1 | · | 4.0 | 4.7 | 5.2 | · | 5.0 | 6.8 | 3.7 | · | 2.1 | · | 2.4 | · | 6.2 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.3 | 0.0 | · | 0.0 | · | 0.0 | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.07 | $5.00 | · | $3.67 | $3.96 | $4.23 | · | $4.77 | $4.40 | $3.44 | · | $4.90 | · | $4.80 | · | $4.25 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | · | · | $0.00 | $1.26 | $0.00 | · | $12.28 | $14.24 | $4.94 | · | · | |
| Cash Flow / Share | · | $-0.25 | · | · | · | $-0.24 | · | · | · | $-407.91 | · | · | · | $-403.80 | · | · | |
| Cash / Share | $0.64 | $0.75 | · | $0.87 | $0.79 | $0.78 | · | $1.35 | $1.39 | $0.64 | · | $0.58 | · | $0.56 | · | $1.75 | |
| EPS (TTM) | $-1.21 | $-1.15 | · | $-1.12 | $-1.16 | $-0.01 | · | $-0.32 | $-0.36 | $-1.61 | · | $-1.64 | $-1.76 | $-2.21 | · | $-2.56 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $80M | · | $81M | $82M | $3M | · | $3M | $3M | $4M | · | $11M | |
| Net Income TTM | $-85M | $-76M | · | $-71M | $-73M | $-510.0K | · | $-18M | $-20M | $-99M | · | $-99M | $-98M | $-109M | · | $-107M | |
| Market Cap | $279M | $511M | · | $498M | $372M | $155M | · | $193M | $386M | $587M | · | $231M | · | $176M | · | $421M | |
| P/E | -3.0 | -6.7 | · | -8.2 | -5.9 | -288.0 | · | -11.2 | -17.2 | -5.9 | · | -2.7 | -1.9 | -1.3 | · | -3.2 | |
| P/S | · | · | · | · | · | 1.9 | · | 2.4 | 4.7 | 233.7 | · | 88.3 | · | 43.5 | · | 39.3 | |
| P/B | 0.9 | 1.5 | · | 2.5 | 1.7 | 0.7 | · | 0.7 | 1.4 | 2.7 | · | 0.9 | · | 0.6 | · | 1.9 | |
| P / Tangible Book | 0.9 | 1.5 | · | 2.5 | 1.7 | 0.7 | · | 0.7 | 1.4 | 2.7 | · | 0.9 | · | 0.6 | · | 1.9 | |
| P / Cash Flow | · | -27.2 | · | · | · | -10.2 | · | · | · | -23.2 | · | · | · | -7.3 | · | · | |
| Earnings Yield | -33.1% | -15.0% | · | -12.2% | -16.9% | -0.35% | · | -9.0% | -5.8% | -17.1% | · | -36.9% | -53.3% | -77.5% | · | -31.6% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $0 | $80M | $3M | $6M | $19M |
| Margen Operativo % | · | -27.4% | -3945.2% | -1774.8% | · |
| Beneficio neto | $-75M | $-10M | $-97M | $-110M | $-81M |
| EPS Diluido | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 27.4 | 22.6 | 17.7 | 12.4 | · |
| Ratio Rápido | 15.1 | 5.3 | 1.9 | 2.1 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-60M | $-2M | $-91M | $-99M | · |
Propietarios institucionales (13F) 167 declarantes · $328.0M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
167
Valor en tenencia
$328.0M
Nuevas posiciones
30
Posiciones cerradas
40
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 30 (-8 vs trimestre anterior) | 40 (+4 vs trimestre anterior) | 75 (0 vs trimestre anterior) | 35 (-4 vs trimestre anterior) | +7.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $40 258 533 | 3 559 552 | 12,28% | Acciones |
| BlackRock, Inc. | $32 296 788 | 8 824 259 | 9,85% | Acciones |
| EcoR1 Capital, LLC | $23 972 510 | 6 549 866 | 7,31% | Acciones |
| TANG CAPITAL MANAGEMENT LLC | $23 868 368 | 6 521 412 | 7,28% | Acciones |
| Nantahala Capital Management, LLC | $20 038 646 | 5 475 040 | 6,11% | Acciones |
| MONTANOVA CAPITAL, LLC | $13 472 171 | 3 680 921 | 4,11% | Acciones |
| D. E. Shaw & Co., Inc. | $11 142 449 | 3 044 385 | 3,40% | Acciones |
| CITADEL ADVISORS LLC | $9 898 488 | 2 704 505 | 3,02% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $9 871 811 | 2 697 216 | 3,01% | Acciones |
| JANE STREET GROUP, LLC | $8 116 043 | 2 217 498 | 2,47% | Acciones |
| STATE STREET CORP | $7 455 512 | 2 037 025 | 2,27% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7 320 000 | 2 000 000 | 2,23% | Acciones |
| GSK plc | $6 535 713 | 1 785 714 | 1,99% | Acciones |
| Qube Research & Technologies Ltd | $6 399 389 | 1 748 467 | 1,95% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $6 030 948 | 1 647 800 | 1,84% | Acciones |
| ADAR1 Capital Management, LLC | $5 728 006 | 1 565 029 | 1,75% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $5 438 039 | 1 485 803 | 1,66% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $5 242 680 | 1 432 133 | 1,60% | Acciones |
| MARSHALL WACE, LLP | $4 971 828 | 1 358 423 | 1,52% | Acciones |
| UBS Group AG | $4 589 307 | 1 253 909 | 1,40% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4 322 262 | 1 180 946 | 1,32% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $4 037 935 | 1 103 261 | 1,23% | Acciones |
| GOLDMAN SACHS GROUP INC | $4 005 595 | 1 094 425 | 1,22% | Acciones |
| Ikarian Capital, LLC | $3 839 929 | 1 049 161 | 1,17% | Acciones |
| BANK OF AMERICA CORP /DE/ | $3 817 486 | 1 043 029 | 1,16% | Acciones |
| Jump Financial, LLC | $3 678 300 | 1 005 000 | 1,12% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $3 515 976 | 960 547 | 1,07% | Acciones |
| Assenagon Asset Management S.A. | $3 056 847 | 835 204 | 0,93% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $2 974 724 | 812 766 | 0,91% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 862 647 | 782 144 | 0,87% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $2 727 860 | 745 317 | 0,83% | Acciones |
| Balyasny Asset Management L.P. | $2 534 082 | 692 372 | 0,77% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $2 495 505 | 681 832 | 0,76% | Acciones |
| Point72 Asset Management, L.P. | $2 384 223 | 651 427 | 0,73% | Acciones |
| NORTHERN TRUST CORP | $1 785 600 | 487 869 | 0,54% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 585 585 | 433 220 | 0,48% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 265 072 | 345 648 | 0,39% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 112 596 | 303 988 | 0,34% | Acciones |
| Peapod Lane Capital LLC | $1 046 021 | 285 798 | 0,32% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 043 408 | 285 084 | 0,32% | Acciones |
| Engineers Gate Manager LP | $885 720 | 242 000 | 0,27% | Acciones |
| EntryPoint Capital, LLC | $794 948 | 217 199 | 0,24% | Acciones |
| XTX Topco Ltd | $765 844 | 209 247 | 0,23% | Acciones |
| CITADEL ADVISORS LLC | $743 712 | 203 200 | 0,23% | Opción de venta |
| Quadrature Capital Ltd | $692 176 | 189 119 | 0,21% | Acciones |
| MORGAN STANLEY | $674 143 | 184 192 | 0,21% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $641 964 | 175 400 | 0,20% | Opción de venta |
| ALLIANCEBERNSTEIN L.P. | $639 448 | 83 370 | 0,19% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $570 477 | 155 868 | 0,17% | Acciones |
| Nuveen, LLC | $566 828 | 154 871 | 0,17% | Acciones |
Informantes de la empresa 29 insiders · 13 directivos · 13 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Alex Sapir | President & Chief Executive Officer | 2 de febrero de 2026 A | 193 360 | 0 | 0 | $0 |
| Bryan Stuart | President & Chief Executive Officer | 19 de enero de 2022 A | 0 | 0 | 0 | $0 |
| Esther Rajavelu | Chief Financial Officer | 9 de febrero de 2023 A | · | 0 | 0 | $0 |
| Judith Dunn | President, Research & Development | 19 de enero de 2022 A | · | 0 | 0 | $0 |
| Melvin H. Hayes III | Chief Operating Officer | 26 de abril de 2023 A | · | 0 | 0 | $0 |
| Greg Tourangeau | Principal Accounting Officer | 2 de febrero de 2026 A | 14 062 | 0 | 0 | $0 |
| Curtis Gale Oltmans | Chief Legal Officer | 2 de febrero de 2026 A | 10 252 | 0 | 1 | $-44 600 |
| Patrick Taylor Horn | Chief Medical Officer | 18 de marzo de 2024 A | · | 0 | 0 | $0 |
| Santiago Arroyo | Chief Medical Officer | 7 de noviembre de 2022 A | · | 0 | 0 | $0 |
| Christopher Morabito | Chief Medical Officer | 19 de enero de 2022 A | 1 100 | 0 | 0 | $0 |
| Christopher Moxham | Chief Scientific Officer | 10 de agosto de 2021 M | 0 | 0 | 0 | $0 |
| Owen B. Wallace | Chief Scientific Officer | 14 de septiembre de 2020 M | 133 438 | 0 | 0 | $0 |
| Diego Cadavid | SVP Clinical Development | 1 de julio de 2020 S | 65 714 | 0 | 0 | $0 |
| Sonja Banks | Consejero | 30 de junio de 2026 A | · | 0 | 0 | $0 |
| Alan Ezekowitz | Consejero | 30 de junio de 2026 A | 10 927 | 0 | 1 | $-65 700 |
| Colin Hill | Consejero | 30 de junio de 2026 A | · | 0 | 0 | $0 |
| Kate Haviland | Consejero | 30 de junio de 2026 A | · | 0 | 0 | $0 |
| Katina Dorton | Consejero | 30 de junio de 2026 A | · | 0 | 0 | $0 |
| Rachel K. King | Consejero | 30 de junio de 2026 A | · | 0 | 0 | $0 |
| Robert J Gould | Consejero | 30 de junio de 2026 A | 469 864 | 0 | 4 | $-667 350 |
| James A Geraghty | Consejero | 30 de junio de 2026 A | 90 714 | 0 | 0 | $0 |
| Joshua Lehrer-Graiwer | Consejero | 23 de abril de 2026 A | · | 0 | 0 | $0 |
| James J. Collins | Consejero | 17 de junio de 2024 A | · | 0 | 0 | $0 |
| Mark J Levin | Consejero | 10 de noviembre de 2021 J | 3 962 202 | 0 | 0 | $0 |
| 6 Dimensions Capital, L.P. | Propietario del 10% | 22 de julio de 2019 C | 559 821 | 0 | 0 | $0 |
| GSK plc | Propietario del 10% | 22 de julio de 2019 C | 1 785 714 | 0 | 0 | $0 |
| Sanofi | Propietario del 10% | 22 de julio de 2019 C | 558 035 | 0 | 0 | $0 |
| Alan A Musso | · | 2 de febrero de 2026 A | · | 0 | 0 | $0 |
| Peter G. Thomson | · | 19 de enero de 2022 A | 2 300 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 20 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0,50% | 29 016 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,05% | 202 049 SH | 10 de septiembre de 2026 | Diario |
| IBB · iShares Trust | 0,02% | 555 962 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 5 408 SH | 2 de octubre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 103 543 SH | 2 de octubre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,01% | 53 282 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 341 378 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 50 849 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 1 524 331 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 28 359 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 54 992 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 93 958 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 110 448 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 23 393 SH | 3 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,00% | 10 048 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 553 375 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 074 332 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5 108 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,00% | 140 406 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 564 368 SH | 11 de septiembre de 2026 | Diario |
FULC Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 11 analistas
VENTA
Objetivo mediano
$4.00
+8,4%
0 0,0%
Compra fuerte
0 0,0%
Compra
7 63,6%
Mantener
2 18,2%
Venta
2 18,2%
Venta fuerte
Precio objetivo a 12 meses
3 analistas · 2026-10-04Objetivo medio $3.67 -0,6%
Ahora
Precio Actual $3.69
Mín$3.00
Media$3.67
Máx$4.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Jul 30, 2026